These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28536390)

  • 1. Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts.
    Huang JL; LaRocca CJ; Yamamoto M
    Biomedicines; 2016 Sep; 4(3):. PubMed ID: 28536390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers.
    Du T; Shi G; Li YM; Zhang JF; Tian HW; Wei YQ; Deng H; Yu DC
    Cancer Gene Ther; 2014 Aug; 21(8):340-8. PubMed ID: 25034886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors.
    Gibson H; Munns S; Freytag S; Barton K; Veenstra J; Bettahi I; Bissonette J; Wei WZ
    Oncoimmunology; 2015 Jan; 4(1):e984523. PubMed ID: 25949865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
    Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
    Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses.
    Zhu M; Bristol JA; Xie Y; Mina M; Ji H; Forry-Schaudies S; Ennist DL
    J Virol; 2005 May; 79(9):5455-65. PubMed ID: 15827160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic Adenovirus: Prospects for Cancer Immunotherapy.
    Zhao Y; Liu Z; Li L; Wu J; Zhang H; Zhang H; Lei T; Xu B
    Front Microbiol; 2021; 12():707290. PubMed ID: 34367111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.
    Bernt KM; Ni S; Tieu AT; Lieber A
    Cancer Res; 2005 May; 65(10):4343-52. PubMed ID: 15899826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current development in adenoviral vectors for cancer immunotherapy.
    Biegert GWG; Rosewell Shaw A; Suzuki M
    Mol Ther Oncolytics; 2021 Dec; 23():571-581. PubMed ID: 34938857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-Tumor Effect of a Novel Oncolytic Virus Based on Chimpanzee Adenovirus Type 6].
    Wang Q; Wang YH; Li Y; Xing M; Zhou DM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):71-76. PubMed ID: 35048603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
    Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
    J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.
    Morales-Molina A; Gambera S; Leo A; García-Castro J
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model.
    Kuryk L; Møller AW; Garofalo M; Cerullo V; Pesonen S; Alemany R; Jaderberg M
    J Med Virol; 2018 Oct; 90(10):1669-1673. PubMed ID: 29797583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model.
    Lee JH; Roh MS; Lee YK; Kim MK; Han JY; Park BH; Trown P; Kirn DH; Hwang TH
    Cancer Gene Ther; 2010 Feb; 17(2):73-9. PubMed ID: 19629143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas.
    Malhotra S; Kim T; Zager J; Bennett J; Ebright M; D'Angelica M; Fong Y
    Surgery; 2007 Apr; 141(4):520-9. PubMed ID: 17383529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.
    Robinson M; Li B; Ge Y; Ko D; Yendluri S; Harding T; VanRoey M; Spindler KR; Jooss K
    J Virol; 2009 Apr; 83(8):3450-62. PubMed ID: 19193803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.
    Bramante S; Kaufmann JK; Veckman V; Liikanen I; Nettelbeck DM; Hemminki O; Vassilev L; Cerullo V; Oksanen M; Heiskanen R; Joensuu T; Kanerva A; Pesonen S; Matikainen S; Vähä-Koskela M; Koski A; Hemminki A
    Int J Cancer; 2015 Oct; 137(7):1775-83. PubMed ID: 25821063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors.
    Lei N; Shen FB; Chang JH; Wang L; Li H; Yang C; Li J; Yu DC
    Cancer Gene Ther; 2009 Jan; 16(1):33-43. PubMed ID: 18670453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.